Department of Health and Human Services March 10, 2017 – Federal Register Recent Federal Regulation Documents

Select Agents and Toxins
Document Number: 2017-04799
Type: Rule
Date: 2017-03-10
Agency: Department of Health and Human Services, Public Health Service
Submission for OMB Review; Comment Request
Document Number: 2017-04752
Type: Notice
Date: 2017-03-10
Agency: Department of Health and Human Services, Administration for Children and Families
CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment
Document Number: 2017-04742
Type: Notice
Date: 2017-03-10
Agency: Department of Health and Human Services, Health Resources and Services Administration
In accordance with the Federal Advisory Committee Act, notice is hereby given that a meeting is scheduled for the Centers for Disease Control and Prevention (CDC)/Health Resources and Services Administration (HRSA) Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment. This meeting will be open to the public. Information about the CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment and the meeting agenda can be obtained by contacting CDR Holly Berilla at (301) 443-9965 or hberilla@hrsa.gov.
National Committee on Vital and Health Statistics: Teleconference
Document Number: 2017-04740
Type: Notice
Date: 2017-03-10
Agency: Department of Health and Human Services
National Institute of Environmental Health Sciences; Notice of Closed Meeting
Document Number: 2017-04711
Type: Notice
Date: 2017-03-10
Agency: Department of Health and Human Services, National Institutes of Health
National Institute of Arthritis and Musculoskeletal and Skin Diseases; Notice of Closed Meeting
Document Number: 2017-04710
Type: Notice
Date: 2017-03-10
Agency: Department of Health and Human Services, National Institutes of Health
National Heart, Lung, and Blood Institute; Notice of Closed Meetings
Document Number: 2017-04709
Type: Notice
Date: 2017-03-10
Agency: Department of Health and Human Services, National Institutes of Health
National Heart, Lung, and Blood Institute; Notice of Closed Meetings
Document Number: 2017-04708
Type: Notice
Date: 2017-03-10
Agency: Department of Health and Human Services, National Institutes of Health
National Heart, Lung, and Blood Institute; Notice of Closed Meeting
Document Number: 2017-04707
Type: Notice
Date: 2017-03-10
Agency: Department of Health and Human Services, National Institutes of Health
Eunice Kennedy Shriver National Institute of Child Health and Human Development; Notice of Closed Meeting
Document Number: 2017-04706
Type: Notice
Date: 2017-03-10
Agency: Department of Health and Human Services, National Institutes of Health
National Institute of Allergy and Infectious Diseases Amended; Notice of Meeting
Document Number: 2017-04705
Type: Notice
Date: 2017-03-10
Agency: Department of Health and Human Services, National Institutes of Health
National Institute on Drug Abuse; Notice of Closed Meeting
Document Number: 2017-04704
Type: Notice
Date: 2017-03-10
Agency: Department of Health and Human Services, National Institutes of Health
Office of the Director, National Institutes of Health; Notice of Meeting
Document Number: 2017-04703
Type: Notice
Date: 2017-03-10
Agency: Department of Health and Human Services, National Institutes of Health
Agency Information Collection Activities; Submission to OMB for Review and Approval; Public Comment Request
Document Number: 2017-04612
Type: Notice
Date: 2017-03-10
Agency: Department of Health and Human Services, Office of the Secretary
In compliance with section 3507(a)(1)(D) of the Paperwork Reduction Act of 1995, the Office of the Secretary (OS), Department of Health and Human Services, has submitted an Information Collection Request (ICR), described below, to the Office of Management and Budget (OMB) for review and approval. The ICR is for reinstatement of a previously-approved information collection assigned OMB control number 0990-0324, which expired on March 31, 2011. Comments submitted during the first public review of this ICR will be provided to OMB. OMB will accept further comments from the public on this ICR during the review and approval period.